Перший досвід застосування в Україні безелектродної системи кардіостимуляції

О.М. Грицай, Я.В. Скибчик, Є.В. Житинський, В.О. Куць, О.Й. Жарінов

Література  

1. Afzal MR, Daoud EG, Cunnane R. et al. Techniques for successful early retrieval of the micra transcatheter pacing system: a worldwide experienc. Heart Rhythm. 2018;15(6):841–846. doi: 10.1016/j.hrthm.2018.02.008
2. Al-Mohaisen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverter-defibrillator. J Am Soc Echocardiogr. 2012;25:245–252. doi: 10.1016/j.echo.2011.11.020
3. Bhatia N, El-Chami M. Leadless pacemakers: a contemporary review. J Geriatric Cardiology. 2018;15:249–253. doi: 10.11909/j.issn.1671-5411.2018.04.002
4. Buch E, Boyle NG, Belott PH. Pacemaker and defibrillator lead extraction. Circulation. 2011;123:e378–380. doi: 10.1161/CIRCULATIONAHA.110.987354
5. DeSimone CV, Friedman PA, Noheria A. et al. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale. Circulation. 2013;128:1433–1441. doi: 10.1161/CIRCULATIONAHA.113.003540
6. Duray GZ, Ritter P, El-Chami M. et al. Long-term performance of a transcatheter pacing system: 12-month results from the micra transcatheter pacing study. Heart Rhythm. 2017;14:702–709. doi: 10.1016/j.hrthm.2017.01.035 
7. Epstein AE, DiMarco JP, Ellenbogen KA. et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;51(21):e1–e62. doi: 10.1016/j.jacc.2008.02.032
8. Johansen JB, Jørgensen OD, Møller M. et al. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011;32:991–998. doi: 10.1093/eurheartj/ehq497
9. Kirkfeldt RE, Johansen JB, Nohr EA. et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35:1186–1194. doi: 10.1093/eurheartj/eht511
10. Kirkfeldt RE, Johansen JB, Nohr EA. et al. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Heart Rhythm. 2011;8:1622–1628. doi: 10.1016/j.hrthm.2011.04.014
11. Knops RE, Tjong FVY, Neuzil P. et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS Trial. J Am Coll Cardiol. 2015;65:1497–1504. doi: 10.1016/j.jacc.2015.02.022
12. Lloyd M, Reynolds D, Sheldon T, et al. Rate adaptive pacing in an intracardiac pacemaker. Heart Rhythm. 2017;14:200–205. doi: 10.1016/j.hrthm.2016.11.016
13. Maytin M, Epstein LM, Henrikson CA. Lead extraction is preferred for lead revisions and system upgrades: when less is more. Circ Arrhythm Electrophysiol. 2010;3:413–424. doi: 10.1161/CIRCEP.110.9541
14. Compton SJ, DiMarco JP, Hackett K. et al. Medtronic. Cardiac Rhythm Disease Management. Product Performance Report. 2013 Second Edition – Issue 68. Available at: wwwp.medtronic.com/productperformance-files/.
15. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009 – a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol. 2011;34:1013–1027. doi: 10.1111/j.1540-8159.2011.03150.x
16. Mondésert B, Dubuc M, Khairy P. et al. Combination of a leadless pacemaker and subcutaneous defibrillator: first in human report. Heart Rhythm Case Rep. 2015;1:469–471. doi: 10.1016/j.hrcr.2015.07.009
17. Niek EG, Beurskens L, Fleur VY. et al. Successful replacement of the longest worldwide in situ Nanostim leadless cardiac pacemaker for a Micra Transcatheter Pacing System. J Interv Cardiac Electrophysiology. 2018;51:161–162. doi: 10.1007/s10840-017-0310-2
18. Okabe T, El-Chami MF, Lloyd MS. et al. Leadless pacemaker implantation and concurrent atrioventricular junction ablation in patients with atrial fibrillation. Pacing Clin Electrophysiol Published Online First: Feb 24, 2018. doi: 10.1111/pace. 13312
19. Piccini JP, Stromberg K, Jackson KP. et al. Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial. Heart Rhythm. 2017;14:685–691. doi: 10.1016/j.hrthm.2017.01.026
20. Przybylski A, Derejko P, Kwasniewski W. et al. Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry. Neth Heart J. 2010;18:230–235. doi: 10.1007/BF03091768
21. Reddy VY, Knops RE, Sperzel JS. et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014;129:1466–1471. doi: 10.1161/CIRCULATIONAHA.113.006987
22. Reddy VY, Exner DV, Cantillon DJ. et al. LEADLESS II. Percutaneous implantation of an entirely intracardiac leadless pacemaker. New Engl J Med. 2015;373:1125–1135. doi: 10.1056/NEJMoa1507192
23. Reynolds D, Duray GZ, Omar R. et al. A leadless intracardiac transcatheter pacing system. New Engl J Med. 2016;374:533–541. doi: 10.1056/NEJMoa1511643
24. Roberts PR, Clementy N, Al Samadi F, Garweg C, Martinez-Sande JL, Iacopino S, Johansen JB, Prat XV, Kowal RC, Klug D, Mont L, Steffel J, Li S, van Osch D, El-Chami MF. A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 2017;14:1375–1379. doi: 10.1016/j.hrthm.2017.05.017
25. Tjong FVY, Reddy VY. Permanent leadless cardiac pacemaker therapy. A comprehensive review. Circulation. 2017;135:1458–1470. doi: 10.1161/CIRCULATIONAHA.116.025037
26. Tjong FV, Brouwer TF, Kooiman KM. et al. Communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable defibrillator. J. Am. Coll. Cardiol. 2016;67:1865–1866. doi: 10.1016/j.jacc.2016.02.039
27. Tracy CM, Epstein AE, Darbar D. et al. 2012 ACCF/AHA/ HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 2013;61:e6–e755. doi: 10.1016/j.jtcvs.2012.08.032
28. Udo EO, Zuithoff NP, van Hemel NM. et al. Incidence and predictors of shortand long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9:728–735. doi: 10.1016/j.hrthm.2011.12.014
29. Vamos M, Erath JW, Benz AP. et al. Incidence of cardiac perforation with conventional and with leadless pacemaker systems: a systematic review and meta-analysis. J. Cardiovasc. Electrophysiol. 2017;28:336–346. doi: 10.1111/jce.13140
30. Yarlagadda B, Turagam MK, Dar T. et al. Safety and feasibility of leadless pacemaker in patients undergoing atrioventricular node ablation for atrial fibrillation. Heart Rhythm. 2018;15(7):994–1000. doi: 10.1016/j.hrthm.2018.02.025